Evidence guide

BPC-157 Dosage

Controlled human evidence does not establish a validated BPC-157 dosage schedule. Most efficacy claims still come from animal models.

Human data are sparse

The human literature consists of very small pilots and uncontrolled reports.

Animal doses do not translate directly

Species, route, formulation, and endpoint all change interpretation.

No approved label

BPC-157 is not FDA-approved for any indication.

What the evidence can support

BPC-157 has a substantial preclinical literature, but the central dosage question requires controlled human pharmacology and dose-ranging studies. Those data are not available at a level that supports a general schedule.

Why online schedules overstate certainty

They often extrapolate from animal models without validated human conversion.
They combine different routes and formulations as if they were equivalent.
They rarely establish product identity, purity, sterility, or stability.